Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
Crinetics Pharmaceuticals Cash and Short Term Investments (Annual) : 1.028B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.028B |
| December 31, 2024 | 1.355B |
| December 31, 2023 | 558.56M |
| December 31, 2022 | 334.42M |
| December 31, 2021 | 333.71M |
| Date | Value |
|---|---|
| December 31, 2020 | 170.88M |
| December 31, 2019 | 118.39M |
| December 31, 2018 | 163.88M |
| December 31, 2017 | 14.19M |
| December 31, 2016 | 12.15M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Johnson & Johnson | 20.10B |
| Eli Lilly & Co. | 7.268B |
| Bristol Myers Squibb Co. | 10.67B |
| Corcept Therapeutics, Inc. | 372.15M |